Indian Supreme Court rules Glivec invalid
Straightforward application of the law
But ruling stokes fear among patent owners
Section 3(d) needs more clarification
The Indian Supreme Court's denial of Novartis's Glivec patent last month prompted dire warnings about patent protection in India, but practitioners warn the ruling should not...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.